T0	Participants 65 115	systemic inflammatory response to cardiac surgery.
T1	Participants 690 759	Patients scheduled for coronary artery bypass graft surgery with CPB.
T2	Participants 818 845	n = 22) or placebo (n = 21)
T3	Participants 1845 1881	patients undergoing cardiac surgery.